-transparent.png){kind=logo}
The results of treatment of 29 patients with Darier's disease with the aromatic retinoid Ro 10-9359 are reported. Therapeutic tests for a period of more than 18 months seem to justify its use in Darier's disease. With a modest dose it is possible to keep the symptoms at an acceptable level, i. e., 50% clearing or more without too troublesome side effects. Because of the side effects the dosage must be fixed individually. It is pointed out that with the development of Ro 10-9359, an efficient remedy for Darier's disease has become available for the first time.
Related Publications
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
October 1981,
The New Zealand medical journal,
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
August 1982,
Dermatologische Monatschrift,
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
August 1981,
The New Zealand medical journal,
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
February 1980,
The British journal of dermatology,
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
January 1978,
Medicina cutanea ibero-latino-americana,
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
September 1983,
Zeitschrift fur Hautkrankheiten,
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
July 1983,
Clinical and experimental dermatology,
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
January 1982,
Acta dermato-venereologica,
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
January 1977,
Dermatologica,
J V Christiansen, and
P Holm, and
R Møller, and
F Reymann, and
H Schmidt
January 1980,
Acta dermato-venereologica,
